Skip to main navigation Skip to search Skip to main content

Consensus Report From the Miami Liver Proton Therapy Conference

  • Michael D Chuong
  • , Adeel Kaiser
  • , Fazal Khan
  • , Parag J Parikh
  • , Edgar Ben-Josef
  • , Christopher Crane
  • , Thomas Brunner
  • , Toshiyuki Okumura
  • , Niek Schreuder
  • , Søren M Bentzen
  • , Alonso Gutierrez
  • , Alejandra Mendez Romero
  • , Sang-Min Yoon
  • , Navesh Sharma
  • , Taeyun Kim
  • , Kazushi Kishi
  • , Fred Moeslein
  • , Sarah Hoffe
  • , Tracey Schefter
  • , Steven Hanish
  • Marta Scorsetti, Smith Apisarnthanarax

Research output: Contribution to journalArticlepeer-review

Abstract

An international group of 22 liver cancer experts from 18 institutions met in Miami, Florida to discuss the optimal utilization of proton beam therapy (PBT) for primary and metastatic liver cancer. There was consensus that PBT may be preferred for liver cancer patients expected to have a suboptimal therapeutic ratio from XRT, but that PBT should not be preferred for all patients. Various clinical scenarios demonstrating appropriateness of PBT vs. XRT were reviewed.

Original languageAmerican English
JournalFront Oncol
Volume9
StatePublished - Jan 1 2019

Cite this